Top 10 Advances in T1D Research

JDRF-supported progress in fiscal year 2014 JDRF sets ambitious goals for progress in type 1 diabetes (T1D) research each year because our supporters inspire us to aim higher. We invite you to read about the real impact our strategic plan is making and hope you are as inspired as we are as each of these […]

15th Annual Spring Research Briefing

Thomas P. Brobson, National Director, Research Investment Opportunities speaks about the latest advances in type 1 diabetes research at the Annual Spring Research Briefing held at the Sheraton Needham Hotel. Mr. Brobson’s Presentation is split into four parts, see below.                                 […]

Redefining the Diagnosis of Type 1 Diabetes

Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]

14th Annual Spring Research Briefing

The 14th Annual Spring Research Briefing was held on April 9, 2013 at the Sheraton Needham Hotel. Dr. Julia Greenstein, JDRF’s Vice President of Cure Therapies, started the evening by providing an overview of JDRF’s research portfolio.  JDRF is driving research across the entire scientific spectrum, from discovery in the laboratory to delivery of new […]